Overview PTH Comparison in Post Menopausal Women Status: Completed Trial end date: 2004-06-01 Target enrollment: Participant gender: Summary Compare in postmenopausal women with established osteoporosis the effect of treatment with teriparatide 20 micrograms/day subcutaneous with the effect of salmon calcitonin 100 IU/day subcutaneous on change in lumbar spine BMD. Phase: Phase 3 Details Lead Sponsor: Eli Lilly and CompanyTreatments: CalcitoninCalcitonin Gene-Related PeptideKatacalcinSalmon calcitoninTeriparatide